late january added effects minimal older people benefited younger ones based fundamental immunology initial data expectation work older adults younger adults zaks said dowling skeptical novel tactic billions doses needed worldwide confident zaks protect older vulnerable people vaccine works not scaled vaccine not work scaled dowling says approach natasa strbo microbiologist immunologist university miami north carolina research protein called gp96 triggers targeted immune response broader innate especially lungs gut reproductive tract proper activation innate immune responses driving successful vaccine immune response doubt strbo says sense adds gp96 acts vaccine adjuvant hopefully work older 60 levy dowling admit vaccines ahead efforts